Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cleveland Research Downgrades Roku to Neutral

Cleveland Research Downgrades Roku to Neutral

Cleveland Research downgrades Roku (NASDAQ:ROKU) from Buy to Neutral.

byBenzinga Newsdesk

October 26, 2022

1 minute read

Cleveland Research downgrades Roku (NASDAQ:ROKU) from Buy to Neutral.

News

Seeking More Equitable Contract, Kroger Health Sends Notice Of Intent To Terminate To Express Scripts

By Benzinga Newsdesk

September 30, 12:32 PM

Express Scripts drug pricing model is unsustainable for Kroger and consumers; access to affordable prescriptions and wellness services remains company's top priority CINCINNATI, Sept. 30, 2022 /PRNewswire/

Google Cloud’s Singapore Alliance: A Beacon for AI Innovation and Investor Opportunities

By Anusuya Lahiri

February 7, 1:46 PM

Google Cloud execs recognize Singapore as a top global AI hub due to innovation-friendly environment and strong public-private partnerships.

AMZN

Cinemark Delivers Blockbuster Q3 Show: Sales Leap On Entertaining 62M Global Moviegoers, EPS Exceeds Expectations

By Nabaparna Bhattacharya

November 3, 12:09 PM

Cinemark Holdings Inc (NYSE: CNK) reported third-quarter FY23 sales growth of 34.5% year-on-year to $874.80 million,

CNK

Jefferies Upgrades Aligos Therapeutics to Buy, Raises Price Target to $3

By Benzinga Newsdesk

January 6, 6:24 AM

Jefferies analyst Michael Yee upgrades Aligos Therapeutics (NASDAQ:ALGS) from Hold to Buy and raises the price target from $2.5 to $3.

ALGS

Cleveland Research Downgrades Roku to Neutral

Related Posts

Seeking More Equitable Contract, Kroger Health Sends Notice Of Intent To Terminate To Express Scripts

Google Cloud’s Singapore Alliance: A Beacon for AI Innovation and Investor Opportunities

Cinemark Delivers Blockbuster Q3 Show: Sales Leap On Entertaining 62M Global Moviegoers, EPS Exceeds Expectations

Jefferies Upgrades Aligos Therapeutics to Buy, Raises Price Target to $3